AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 89 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,815,676 | -36.4% | 2,409,289 | +1.7% | 12.25% | -28.7% |
| Q2 2023 | $39,042,585 | +70.6% | 2,369,089 | -5.2% | 17.18% | +46.6% |
| Q1 2023 | $22,889,355 | +27.1% | 2,498,838 | -0.6% | 11.72% | +14.0% |
| Q4 2022 | $18,006,720 | +38.5% | 2,514,905 | -3.1% | 10.28% | +29.3% |
| Q3 2022 | $13,000,000 | +106.2% | 2,594,760 | +0.4% | 7.95% | +109.5% |
| Q2 2022 | $6,305,000 | -61.2% | 2,584,090 | +8.7% | 3.80% | -49.9% |
| Q1 2022 | $16,237,000 | -12.8% | 2,377,290 | +3.1% | 7.58% | -2.0% |
| Q4 2021 | $18,625,000 | – | 2,305,017 | – | 7.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |